Skip to content
Search
Login
About Us
News
Webinars & Events
Resources
Contact Us
About Us
News
Webinars & Events
Resources
Contact Us
Search
Login
About Us
News
Webinars & Events
Resources
Contact Us
About Us
News
Webinars & Events
Resources
Contact Us
Tag: FDA enforcement
06/19/2019
OPDP Untitled Letter Cites False, Misleading Claims about Efficacy, Risk Presentation for Obesity Drug
Learn More
04/30/2019
OPDP Issues Enforcement Letter for Investigational Drug Promotion
Learn More
03/28/2019
FDA Applies Increased Scrutiny to Nutritional Supplements Claiming Pain Relief
Learn More
02/28/2019
CDRH Issues Warning Letter for Device Cancer Diagnosis Claims in Brochures, on Website
Learn More
11/02/2018
OPDP Cites Lack of Risk Information in Second Warning Letter of 2018
Learn More
07/11/2018
Exhibit Booth and Webpage Misbrand IND, OPDP Says in Enforcement Letter
Learn More
07/02/2018
False/Misleading Risk, Efficacy Claims in Online Video Cited in OPDP Enforcement Letter to Pfizer
Learn More
03/07/2018
CBER’s APLB Issues First Enforcement Letter Since 2015 for Misleading Efficacy Claims
Learn More
02/23/2018
First 2018 OPDP Enforcement Letter Targets Exhibit Booth for Opioid
Learn More
«
Page
1
Page
2
Page
3
Page
4
Page
5
…
Page
7
»
